Hit enter to search or ESC to close
Amphista TherapeuticsAmphista TherapeuticsAmphista Therapeutics
  • Home
  • About
  • Technology
  • Pipeline
  • Careers
  • News
  • Contact
    Category

    Company News

    BlogsCompany News

    It’s not rocket science…

    Discovering new drugs is hard. It’s not rocket science – in fact, it’s much harder than rocket science! When new…
    Chris AdamsDecember 22, 2020
    BlogsCompany News

    The rise and rise of TPD? Personal highlights from the 3rd Annual TPD Summit 14-15th October 2020

    It promised to be the best TPD meeting of the year with everyone from across the rapidly expanding array of…
    Chris AdamsDecember 22, 2020
    Company News

    Amphista Therapeutics appoints Ian Churcher as CSO

    Glasgow, Scotland, 21 May 2020 - Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural…
    adminMay 21, 2020
    Company News

    Amphista Therapeutics raises $7.5m Series A round

    Amphista’s potent bifunctional small molecules augment targeted protein degradation Investors include Advent Life Sciences, the Scottish Investment Bank, the European…
    adminApril 7, 2020

    Upcoming Events

    Amphista will be attending and/or presenting at the following conferences. If you would like to meet with us, please email info@amphista.com.

    Upcoming Events

    • Biotech showcase, 11-15th January 2021
    • Targeted Protein Degradation Europe Summit – 16-18 March 2021
    • BioEquity, April 13-14, 2021, Dublin

    Past Events

    • 3rd Targeted Protein Degredation Summit, October 13-15 2020
    • BioEurope, Munich, 26-28 Oct 2020
    • 5th Medicinal Chemistry & Protein Degradation Summit, Nov 16-17th 2020
    • Genesis, London, 10 Dec 2020

    Categories

    • Blogs
    • Company News
    • Coverage
    • Jobs

    Quick Links

    • About
    • Company News
    • Events
    • Technology

    Legal

    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
    • Contact

    About

    • BioCity, Bo’Ness Rd, Newhouse, Chapelhall, Motherwell, ML1 5UH, UK
    • info@amphista.com

    © 2021 Amphista Therapeutics. All rights reserved | Designed & built by FDM Digital

    • Home
    • About
    • Technology
    • Pipeline
    • Careers
    • News
    • Contact

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in settings.

      Amphista Therapeutics
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      You can adjust all of your cookie settings by navigating the tabs on the left hand side or review our Cookie and Privacy Policy.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

      3rd Party Cookies

      This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

      Keeping this cookie enabled helps us to improve our website.

      Please enable Strictly Necessary Cookies first so that we can save your preferences!

      Cookie Policy

      For more detailed information on our Cookie and Privacy Policy, including the cookies we use and how to request a copy of the data we hold, please click click HERE.